Boai NKY Medical Holdings Ltd.
SHZ: 300109.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Junzheng Zhang
- Employees
- 1,163
- Headquarters
- Jiaozuo, China
- IPO year
- 2010
- Market cap
- CN¥9.8B
- Website
- https://www.boai-nky.com
Loading 300109…
Loading profile data…Frequently asked questions about 300109
What does Boai NKY Medical Holdings Ltd. (300109.SZ) do?
Boai NKY Medical Holdings Ltd. develops, manufactures, and sells polyvinylpyrrolidone (PVP) series products worldwide. The company offers KoVidone and PolyKoVidone line of products representing Povidone, Crospovidone, and Copovidone pharmaceutical excipients; OraRez line of PVM/MA copolymer and derivatives representing functional polymers for bi...
Where does 300109.SZ trade?
Boai NKY Medical Holdings Ltd. (300109.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300109.SZ in?
Boai NKY Medical Holdings Ltd. (300109.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
Who is the CEO of Boai NKY Medical Holdings Ltd.?
Junzheng Zhang is the chief executive officer of Boai NKY Medical Holdings Ltd. (300109.SZ).
Where is Boai NKY Medical Holdings Ltd. headquartered?
Boai NKY Medical Holdings Ltd. is headquartered in China.
Does 300109.SZ pay a dividend?
Yes — Boai NKY Medical Holdings Ltd. (300109.SZ) paid a trailing twelve-month dividend of CNY 0.25 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300109.SZ go public?
Boai NKY Medical Holdings Ltd. (300109.SZ) completed its initial public offering in 2010.